While anecdotal reports suggest GLP-1 drugs may reduce alcohol consumption, a Novo Nordisk spokesperson said a phase 2 trial will be studying semaglutide the active ingredient in Wegovy and Ozempic and related compounds for their effects on alcohol-related liver disease, with drinking habits monitored as a secondary outcome
We serve clients from Northridge, CA, Los Angeles, CA, West LA, Porter Ranch, CA, San Fernando, CA, Calabasas, CA, Woodland Hills, CA, Hidden Hills, CA, Granada Hills, and beyond
The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor
Who is a candidate for Radiesse treatment (and who shouldnt have Radiesse)